HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy.
about
CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanismsShigella flexneri targets the HP1γ subcode through the phosphothreonine lyase OspFBeta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrenceCD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic featuresInterplay between Epigenetics and Genetics in Cancer.Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomasOverexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival.A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis.Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
P2860
Q28392625-C0798148-530C-4FB9-ABAC-ED3FE6AE5202Q34806959-2B101489-7864-451A-BFCF-E0B3513B1879Q34978719-E96B529C-C05A-478F-BA24-E89AF6A16481Q35175294-428E5267-73D6-4345-8C78-21A2C814D057Q35602528-D4A61DF0-7EE0-4F4D-A97A-3B0E998F1F79Q35713085-CC4041D8-102E-47EF-B0B1-7E5D5ECAA9ADQ37500876-6EB67857-C216-458C-BB0E-75860FC1F84CQ37565399-2060D932-9D92-49F5-9D84-EAA1324587E4Q38152999-06D2E05A-AB53-4BD5-9679-1DCC38F150F1Q42007974-3BC4E7CF-5197-46B4-8931-8FFCD5D15CEFQ46250388-8A467BCA-9A3B-4B0C-9031-D1C9F32D6218Q47716690-179D3EC3-CACF-4141-9CCB-044AC1AD59D7Q55016829-704BD8D0-590E-4DDB-A126-8C7388B38B32Q55638534-C1E513C8-4667-4829-A669-229B4E403B73
P2860
HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HP1γ expression is elevated in ...... e after radical prostatectomy.
@ast
HP1γ expression is elevated in ...... e after radical prostatectomy.
@en
HP1γ expression is elevated in ...... e after radical prostatectomy.
@nl
type
label
HP1γ expression is elevated in ...... e after radical prostatectomy.
@ast
HP1γ expression is elevated in ...... e after radical prostatectomy.
@en
HP1γ expression is elevated in ...... e after radical prostatectomy.
@nl
prefLabel
HP1γ expression is elevated in ...... e after radical prostatectomy.
@ast
HP1γ expression is elevated in ...... e after radical prostatectomy.
@en
HP1γ expression is elevated in ...... e after radical prostatectomy.
@nl
P2093
P2860
P356
P1433
P1476
HP1γ expression is elevated in ...... ce after radical prostatectomy
@en
P2093
David Jarrard
Jon Slezak
P2860
P2888
P356
10.1186/1471-2407-13-148
P407
P577
2013-03-23T00:00:00Z
P5875
P6179
1036928850